Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-11-07 | Vaxcyte, Inc. | PICKERING GRANT
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 2366 | $102.64 - $105.50 | $245,793 |
2024-11-07 | Vaxcyte, Inc. | PICKERING GRANT
(CHIEF EXECUTIVE OFFICER) |
M | Common Stock | A | 30792 | $0.04 - $5.35 | $114,307 |
2024-11-01 | Vaxcyte, Inc. | PICKERING GRANT
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 15000 | $106.35 - $108.50 | $1,602,250 |
2024-11-01 | Vaxcyte, Inc. | Wassil Jim
(CHIEF OPERATING OFFICER) |
S | Common Stock | D | 8000 | $106.34 - $108.93 | $854,421 |
2024-11-01 | Vaxcyte, Inc. | Wassil Jim
(CHIEF OPERATING OFFICER) |
M | Common Stock | A | 8000 | $2.42 - $2.42 | $19,360 |
2024-10-28 | Vaxcyte, Inc. | Wassil Jim
(CHIEF OPERATING OFFICER) |
M | Common Stock | A | 5049 | $5.35 - $20.93 | $80,980 |
2024-10-07 | Vaxcyte, Inc. | PICKERING GRANT
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 7098 | $107.27 - $110.35 | $775,151 |
2024-10-07 | Vaxcyte, Inc. | Eydelman Mikhail
(SVP, GEN COUNSEL & CORP SEC) |
S | Common Stock | D | 5000 | $107.51 - $111.68 | $546,350 |
2024-10-07 | Vaxcyte, Inc. | Eydelman Mikhail
(SVP, GEN COUNSEL & CORP SEC) |
M | Common Stock | A | 5000 | $21.41 - $21.41 | $107,050 |
2024-10-01 | Vaxcyte, Inc. | PICKERING GRANT
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 55000 | $113.35 - $114.98 | $6,283,857 |
2024-10-01 | Vaxcyte, Inc. | PICKERING GRANT
(CHIEF EXECUTIVE OFFICER) |
M | Common Stock | A | 40000 | $5.35 - $5.35 | $214,000 |
2024-10-01 | Vaxcyte, Inc. | Wassil Jim
(CHIEF OPERATING OFFICER) |
S | Common Stock | D | 8000 | $113.42 - $114.95 | $913,916 |
2024-10-01 | Vaxcyte, Inc. | Wassil Jim
(CHIEF OPERATING OFFICER) |
M | Common Stock | A | 8000 | $2.42 - $2.42 | $19,360 |
2024-09-18 | Vaxcyte, Inc. | GUGGENHIME ANDREW
(PRESIDENT AND CFO) |
S | Common Stock | D | 8000 | $115.60 - $117.53 | $927,549 |
2024-09-18 | Vaxcyte, Inc. | GUGGENHIME ANDREW
(PRESIDENT AND CFO) |
M | Common Stock | A | 8000 | $5.35 - $5.35 | $42,800 |
2024-09-17 | Vaxcyte, Inc. | Loxam Teri
(Director) |
S | Common Stock | D | 6250 | $114.64 - $117.51 | $726,728 |
2024-09-17 | Vaxcyte, Inc. | Loxam Teri
(Director) |
M | Common Stock | A | 6250 | $22.70 - $22.70 | $141,875 |
2024-09-16 | Vaxcyte, Inc. | Wassil Jim
(CHIEF OPERATING OFFICER) |
S | Common Stock | D | 10000 | $115.06 - $116.96 | $1,159,634 |
2024-09-16 | Vaxcyte, Inc. | Wassil Jim
(CHIEF OPERATING OFFICER) |
M | Common Stock | A | 10000 | $2.42 - $2.42 | $24,200 |
2024-08-23 | Vaxcyte, Inc. | PICKERING GRANT
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 15000 | $78.65 - $79.25 | $1,184,766 |
2024-08-23 | Vaxcyte, Inc. | PICKERING GRANT
(CHIEF EXECUTIVE OFFICER) |
M | Common Stock | A | 15000 | $2.03 - $2.03 | $30,449 |
2024-08-19 | Vaxcyte, Inc. | GUGGENHIME ANDREW
(PRESIDENT AND CFO) |
S | Common Stock | D | 8000 | $78.25 - $79.14 | $628,649 |
2024-08-19 | Vaxcyte, Inc. | GUGGENHIME ANDREW
(PRESIDENT AND CFO) |
M | Common Stock | A | 8000 | $5.35 - $5.35 | $42,800 |
2024-08-01 | Vaxcyte, Inc. | PICKERING GRANT
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 2616 | $78.78 - $78.80 | $206,121 |
2024-08-01 | Vaxcyte, Inc. | Eydelman Mikhail
(SVP, GEN COUNSEL & CORP SEC) |
S | Common Stock | D | 1667 | $78.80 - $79.29 | $131,448 |
2024-08-01 | Vaxcyte, Inc. | Eydelman Mikhail
(SVP, GEN COUNSEL & CORP SEC) |
M | Common Stock | A | 1667 | $21.41 - $21.41 | $35,690 |
2024-07-23 | Vaxcyte, Inc. | PICKERING GRANT
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 15000 | $83.83 - $84.53 | $1,263,910 |
2024-07-23 | Vaxcyte, Inc. | PICKERING GRANT
(CHIEF EXECUTIVE OFFICER) |
M | Common Stock | A | 15000 | $2.03 - $2.03 | $30,449 |
2024-07-08 | Vaxcyte, Inc. | Cowan Elvia
(SVP, FINANCE) |
S | Common Stock | D | 5000 | $80.00 - $80.00 | $400,000 |
2024-07-08 | Vaxcyte, Inc. | Cowan Elvia
(SVP, FINANCE) |
M | Common Stock | A | 5000 | $25.92 - $25.92 | $129,600 |
2024-07-01 | Vaxcyte, Inc. | Eydelman Mikhail
(SVP, GEN COUNSEL & CORP SEC) |
S | Common Stock | D | 1667 | $75.93 - $76.90 | $127,303 |
2024-07-01 | Vaxcyte, Inc. | Eydelman Mikhail
(SVP, GEN COUNSEL & CORP SEC) |
M | Common Stock | A | 1667 | $21.41 - $21.41 | $35,690 |
2024-06-24 | Vaxcyte, Inc. | PICKERING GRANT
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 15000 | $75.39 - $76.80 | $1,134,578 |
2024-06-24 | Vaxcyte, Inc. | PICKERING GRANT
(CHIEF EXECUTIVE OFFICER) |
M | Common Stock | A | 15000 | $2.03 - $2.03 | $30,449 |
2024-06-18 | Vaxcyte, Inc. | GUGGENHIME ANDREW
(PRESIDENT AND CFO) |
S | Common Stock | D | 8000 | $71.89 - $72.56 | $575,374 |
2024-06-18 | Vaxcyte, Inc. | GUGGENHIME ANDREW
(PRESIDENT AND CFO) |
M | Common Stock | A | 8000 | $5.35 - $5.35 | $42,800 |
2024-06-06 | Vaxcyte, Inc. | Drapeau Anne S
(Director) |
A | Common Stock | A | 1550 | $0.00 - $0.00 | $0 |
2024-06-06 | Vaxcyte, Inc. | Hirth Peter
(Director) |
A | Common Stock | A | 1550 | $0.00 - $0.00 | $0 |
2024-06-06 | Vaxcyte, Inc. | Paya Carlos V
(Director) |
A | Common Stock | A | 1550 | $0.00 - $0.00 | $0 |
2024-06-03 | Vaxcyte, Inc. | Eydelman Mikhail
(SVP, GEN COUNSEL & CORP SEC) |
S | Common Stock | D | 1667 | $71.25 - $73.64 | $120,126 |
2024-06-03 | Vaxcyte, Inc. | Eydelman Mikhail
(SVP, GEN COUNSEL & CORP SEC) |
M | Common Stock | A | 1667 | $21.41 - $21.41 | $35,690 |
2024-06-03 | Vaxcyte, Inc. | Wassil Jim
(CHIEF OPERATING OFFICER) |
S | Common Stock | D | 3000 | $71.38 - $73.47 | $215,960 |
2024-06-03 | Vaxcyte, Inc. | PICKERING GRANT
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 2616 | $71.43 - $73.46 | $188,509 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |